Picture of Hofseth Biocare ASA logo

HBC Hofseth Biocare ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Brief: Hofseth Biocare Gets Approval From Health Canada For Qualified Health Claims For Its Salmon Protein Hydrolysate

Oct 19 (Reuters) - Hofseth Biocare ASA  HOFS.OL :
    * GETS APPROVAL FROM HEALTH CANADA FOR QUALIFIED HEALTH
CLAIMS
(QHCS) FOR ITS SALMON PROTEIN HYDROLYSATE (PROGO AND COLLAGO)
    * HBC CAN NOW SELL PROGO® AND COLLAGO® ACROSS WHOLE OF NORTH
AMERICA
    * FURTHERMORE, HEALTH CANADA'S QHCS ARE INTERNATIONALLY
RECOGNIZED
BY MOST ASIAN COUNTRIES

Source text for Eikon:  ID:nGNE4dy5KX 
Further company coverage:  HOFS.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Hofseth Biocare ASA

See all news